Key result
ICD recipients face ~26% long-term mortality, with most deaths occurring in patients with LVEF <35%.
Why the study?
Most major defibrillator trials have short follow-up and may not capture the benefit for patients with preserved left ventricular function or the progressive nature of advanced heart disease.
Does ICD therapy provide long-term survival benefits and lifesaving therapy in patients with preserved left ventricular function?
Cohort (n=124)
No
Does ICD therapy provide long-term survival benefits and lifesaving therapy in patients with preserved left ventricular function?
ICD therapy provides substantial life-saving benefits and low mortality over long-term follow-up, including in patients with preserved left ventricular function.
Answers are grounded in this paper and cite their sources.
High long-term mortality after ICD is largely confined to EF <35%; leaves open survival benefit in preserved EF and requires prospective validation.
OBJECTIVE: Most major defibrillator trials have short follow-up and may neither capture the benefit for those with preserved function nor the progressive nature of advanced heart disease. We intended to investigate the long-term outcome in an unselected population of patients treated with ICD. DESIGN: We followed 124 consecutive patients that received an ICD during 1993-2002 at our institution for a median of 6.1 years. Information about heart disease, index arrhythmia, follow-up and death was extracted from medical records. RESULTS: The crude mortality was 26% (32/124). One- and two-year mortality was 6% and 12%, estimated 5- and 10-year mortality 20% and 33%. The cause of death was heart failure in 75% of deaths. The ejection fraction was below 35% in 91% of the 32 patients who died. We estimated that 28% of the patients received lifesaving therapy. The relative number of saved lives and complications was not related to the ejection fraction. CONCLUSION: Patients with preserved left ventricular function are excellent candidates for ICD, with life-saving ICD therapies in a substantial proportion, low mortality and good quality of life.
No takes yet. Share an insight, caveat, or question.
Rönn et al. (2008) conducted a cohort in Patients treated with an Implantable Cardioverter Defibrillator (ICD) (n=124). Implantable Cardioverter Defibrillator (ICD) was evaluated on Crude mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: